Medical Technology and Devices: from Lab to Patient (HORIZON-EIC-2021-TRANSITIONCHALLENGES-01-01)
EU-funded early-stage Research on novel Medical Technologies and Devices is uncovering unique opportunities to benefits patients and support clinicians.
Medical Technology and Devices businesses are facing long and capital-intensive product development cycles, complex regulatory procedures, slow market uptake requiring the support of key opinion leaders and intensive follow-up with early adopters. In addition to a mature technology, a well thought-out and realistic exploitation path with emphasis on achieving market traction as proof of both clinical and market potential of the idea is needed.
Proposal submitted to this transition challenge call should aim to:
- Perform the necessary R&D to advance from an existing proof-of-principle technology to a mature version to initiate clinical evaluation.
- Develop an exploitation strategy, qualitatively and quantitatively outlining the proposed path to patient and describing an investable proposition.
Proposal submitted to this call can target any technology addressing important health needs in the direct clinical treatment and care of patients.
The EIC considers proposals with a requested EU contribution of up to a EUR 2.5 million and a duration of up to 3 years as appropriate.
For further information on your eligibility, please refer to the EIC Work Programme 2021 in section III.2.1.
For 2021 it is restricted to applications based on results generated by the following eligible projects:
- EIC Pathfinder projects (including projects funded under EIC pilot Pathfinder, Horizon 2020 FET-Open, FET-Proactive) and FET Flagships calls (including ERANET calls under the FET work programme)
- European Research Council (ERC) Proof of Concept projects
